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141In vitro hemodynamic model of the arm
arteriovenous circulation to study hemodynamics
of native arteriovenous ﬁstula and the distal
revascularization and interval ligation procedure
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Background: Experimental modeling of arteriovenous hemodialysis ﬁstula (AVF) hemodynamics is challenging. Mathe-
matical modeling struggles to accurately represent the capillary bed and venous circulation. In vivo animal models are
expensive and labor intensive. We hypothesized that an in vitro, physiologic model of the extremity arteriovenous
circulation with provisions for AVF and distal revascularization and interval ligation (DRIL) conﬁgurations could be
created as a platform for hemodynamic modeling and testing.
Methods: An anatomic, upper extremity arteriovenous model was constructed of tubing focusing on the circulation from
the subclavian artery to subclavian vein. Tubing material, length, diameter, and wall thickness were selected to match
vessel compliance and morphology. All branch points were constructed at physiologic angles. The venous system and
capillary bed were modeled using tubing and one-way valves and compliance chambers. A glycerin/water solution was
created to match blood viscosity. The system was connected to a heart simulator. Pressure waveforms and ﬂows were
recorded at multiple sites along the model for the native circulation, brachiocephalic AVF conﬁguration, and the AVF
with DR without and with IL (DR no IL and DRIL).
Results: A presetmean cardiac output of 4.2 L/min from the heart simulator yielded a subclavian artery pressure of 125/55
mmHg and a brachial artery pressure of 121/54mmHgwith physiologic arterial waveforms.Mean capillary bed perfusion
pressure was 41 mmHg, and mean venous pressure in the distal brachial vein was 17 mmHg with physiologic waveforms.
AVF conﬁguration resulted in a 15% decrease in distal pressure and a 65% decrease in distal ﬂow to the hand. DR no IL had
no change in distal pressure with a 27% increase in distal ﬂow. DRIL resulted in a 3% increase in distal pressure and a 15%
increase in distal ﬂow to the hand above that of DR no IL. Flow through the DR bypass decreased from 329mL/min to 55
mL/min with the addition of IL. Flow through the AVF for both DR no IL and DRIL was preserved.
Conclusions: Through the construction and validation of an in vitro, pulsatile arteriovenous model, the intricate hemody-
namics of AVF and treatments for ischemic steal can be studied. DRwith or without IL improved distal blood ﬂow in addition
to preserving AVF ﬂow. IL decreased the blood ﬂow through the DR bypass itself. The ﬁndings of the AVF as a pressure sink
and the relative role of IL with DR bypass has allowed this model to provide hemodynamic insight difﬁcult or impossible to
obtain in animal or human models. Further study of these phenomena with this model should allow for more effective AVF
placement and maturation while personalizing treatment for associated ischemic steal. (J Vasc Surg 2014;59:1410-7.)
Clinical Relevance: The complications of arteriovenous ﬁstula (AVF)-associated steal with its concurrent surgical treat-
ments have been clinically described but have relatively little published, concrete hemodynamic data. A further under-
standing of the underlying hemodynamics is necessary to prevent the occurrence of steal and improve treatment when it
occurs. Speciﬁc objectives are to study the blood ﬂow through an AVF with varying anatomic and physiologic parameters,
determine what factors contribute to the development of arterial steal distal to an AVF, and create optimal interventions
to treat arterial steal from an AVF when it occurs. The long-term goal is creation of AVF tailored to patient-speciﬁc
parameters, resulting in higher rates of functional ﬁstulas with decreases in ﬁstula-related complications. The ability to
study ﬂuid dynamics using a unique, in vitro, upper extremity pulsatile arteriovenous circulation simulator creates the
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Fig 1. Noncompliant tubing, capable of acquiring pressure
measurements at each junction through pressure transducers
(bottom arrow) and ﬂow through each segment of tubing through
ﬂow probes (top arrow).
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preferred modality for hemodialysis access, the under-
standing of the hemodynamics that underlie their encom-
passing problems lacks clarity. From a ﬂuid dynamics
perspective, little is known as to why AVF creation is
successful for some patients, while others require additional
procedures. In particular, the understanding of the hemo-
dynamics associated with access-related ischemia is incom-
pletely understood. Distal revascularization and interval
ligation (DRIL) is among one of the corrective procedures
improving distal ischemia; however, its underlying hemo-
dynamics are unclear.1-5
Our goal was to create an in vitro model because of its
advantages over expensive, not easily reproducible animal
models. The additional beneﬁts of an in vitro model
include control of all hemodynamic parameters such as
blood pressure, heart rate, resistance, and compliance in
the system. We designed and constructed a highly instru-
mented physical system to help in the understanding of the
hemodynamics of the arm vasculature and used this to quan-
titatively study the hemodynamics effects of AVF andDRIL.
We hypothesize that the development of a vascular
model of the arm, adaptable to AVF and DRIL procedure
conﬁgurations, would allow for investigation into critical
hemodynamic parameters related to distal hand ischemia
after ﬁstula placement. We hypothesize that the AVF
procedure will signiﬁcantly reduce distal hand perfusion,
and DRIL will partially restore this lost perfusion.
METHODS
Material properties. For the consideration of the
materials of the physical model of the arm vasculature,
the resistance and compliance of the vessels needs to be
taken into consideration. To capture the equivalent resis-
tance of the vessels, Poiseuille’s law was applied. The resis-
tance, R, for laminar, steady-state ﬂow through a tube:
R ¼ 128mLp/D4, where m is the viscosity of the ﬂuid, L is
the length of an isolated diameter, D, of tubing.6 By
examining Poiseuille’s law, which represents vascular
resistance in its simplest form, we extract physical param-
eters that potentially have the largest impact on vascular
resistance. Therefore, it was important to emulate the
equivalent length and diameter (the governing parameter
to laminar resistance), by matching these values to average
anatomic values found through a literature search.7,8
Another important physical parameter of the blood
vasculature is the compliance, which results, in part, from
the elasticity, of the vessel. The compliance of any tube
or vessel is a function of parameters such as the diameter,
volume, wall thickness, and wall elasticity.9 Additionally,
static compliance can be deﬁned as the ratio of the change
in volume of a vessel, DV, to the change in pressure of the
vessel, DP: C ¼ DV/DP.
A simple experiment was used to test the static compli-
ance of several different materials by introducing a volu-
metric change to a 30-cm length of tubing through
a syringe and recording the resultant pressure change
through a pressure transducer. Three volumetric changeswere graphed against the resultant pressure changes. The
resulting slope is the static compliance. The 11 samples
of tubing, four Tygon PVC, three silicon, two latex, and
two polyurethane, were compared with the average
anatomic compliance of arteries (0.0121 mL/mm Hg)
and veins (assumed to be three times that of the compli-
ance of arteries).10,11 A Tygon tubing, with a Shore A
wall hardness of 65 for the arterial side (#5553k; McMaster-
Carr, Aurora, Ohio) and a similar, yet softer, Tygon
tubing with a Shore A wall harness of 40 was chosen for
the venous side of the model (#5894k; McMaster-Carr).
Fluid viscosity. As stated in Poisuelle’s law and most
other analytical models of ﬂuidic resistance (such as
Womersley’s Impedance Method), viscosity (m) is directly
proportional to resistance. For an accurate analytical model
to be produced, the viscosity of ﬂuid in the system must
match that of blood. There is substantial variation in phys-
iological viscosities, but a glycerin/water mixture of an
approximate 40/60 ratio yields a viscosity of 3.5 centipoise
(cp). Blood is a non-Newtonian ﬂuid at high shear stresses
due to its composition of erythrocytes, monocytes, plate-
lets, and plasma; however, at low shear stress, the viscosity
of blood can be approximated as 3.5 cp.12,13 The ﬂuid
mixture is composed of 2 liters of 99.9% vegetable-based
glycerin and 3 liters of distilled water. The mixture was
tested with calibrated Cannon Size 50 and Size 100
viscometers, and it was found to yield a 3.43 cp mixture
with 1.5% conﬁdence interval. Prior to ﬁlling the model,
the solution was agitated and the system was allowed to run
for several minutes prior to collecting data to facilitate
keeping the water and glycerin in solution.
Hemodynamic measurements. Polycarbonate barbed
ﬁttings were used to connect the vessel tubing. Each ﬁtting
was then custom fabricated by placing a small non-
compliant tube perpendicular to vessel ﬂow as a pressure
tap. A Leur-Lock ﬁtting was attached to the opposing end
so that a pressure transducer could be easily connected, and
pressure measurements could be made at each junction of
tubing. These pressure taps were created by drilling
a 0.10400 hole into the center of the connector, and then
Fig 2. Schematic of Hemodynamic Simulator Pump (image credited to Matthew DeCapua; published with
permission).
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a quick-cure adhesive (Fig 1).
The pressure transducers were zeroed and allowed to
warm up before every experiment (Deltran I; Utah Medical
Products Inc, West Midvale, Utah). The transducers had an
operating range from50 toþ300 mmHg with a tolerance
of 62%. The pressure monitor used was an HP Component
Monitoring System (M1046-9001C; Hewlett Packard, Palo
Alto, Calif) and had the capability to visually monitor four
pressure measurements simultaneously and output systolic,
diastolic, and mean pressures for each. The pressure signals
were also routed through BNC cables to a National Instru-
ments 8-channel, 16-bit, 1.25 MS/s (NI USB-6251;
National Instruments, Austin, Tex) data acquisition device,
which was used to record all the data in this study.
Four ﬂow probes (ME25PXN, ME10PXL, ME6PXL,
ME3PXL; Transonic Systems Inc, Ithaca, NY) were factory
calibrated to the Tygon tubing used in the arterial portion of
the physical model. The three smaller probes (ME10PXN,
ME6PXN, ME3PXN) were clamp-on ﬂow probes and
were chosen to have the ability to be placed anywhere in
the model. The larger ﬂow probe (ME25PXN) is an inline
ﬂow probe and was placed at the aortic inﬂow to capture
the total input to the system. Having multiple ﬂow probes
allowed for simultaneous ﬂow measurements to be madethroughout the system. Probes were placed in the middle
of the tubing of interest in an attempt to capture fully devel-
oped bulk ﬂow devoid of small eddy currents from connec-
tors. Each of the ﬂow probes was speciﬁed to measure the
ﬂow within 64% of the recorded values. The ﬂow meter
used was a 400-series multichannel ﬂow meter console
T403 (Transonic Systems Inc).
Capillary bed. Because of the intricacy and small
caliber of the capillary bed network, modeling every vessel
in the capillary bed as a distinct tube is infeasible. Inﬂu-
enced by the Hemodynamic Simulator, described next,
a small compliance chamber was fabricated in which ﬂow
ran through from the arterial to the venous side to accu-
rately mimic both the resistance and compliance of the
capillary bed. A speciﬁed amount of pressurized air atop
a column of ﬂuid created a controllable system.
Heart simulator pump. The pump that drove the
pulsatile ﬂow through the system (Fig 2) is a Hemody-
namic Simulator designed as a part of a multidisciplinary
team composed of students under the leadership of our
group. The hemodynamic simulator is capable of output-
ting waveforms that closely resemble physiologic pressures
and ﬂows. At its core, the Hemodynamic Simulator is
driven by a linear actuator (THK VLA-ST-60-12-0250)
powered by a Servo Motor (Sigma-V Series; Yasakawa,
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requires a minimum stroke volume of 70 mL. The actuator
pressurizes a buffer chamber, which then drives ﬂuid
through a ventricular chamber where the ﬂuid must pass
through the ﬁrst of two St Jude heart valves (one mitral,
one aortic). The ﬂuid then passes through a second heart
valve (analogous to the aortic valve), which then enters the
aortic compliance chamber (3.7500 ID, 1000 tall), of which
600 held ﬂuid with the other 400 comprised of pressurized air.
The air in both the arterial and venous compliance cham-
bers was pressurized by sphygmomanometer bulbs. The
ﬂuid then passes through 100 ID tubing analogous to the
aorta and can traverse through a resistance gate valve
(peripheral vascular resistance) or into the tubing of the
arm vasculature. After the resistance valve-arm vasculature
bifurcation, the ﬂuid travels into the venous compliance
chamber (5.7500 ID, 1600 tall with 700 of ﬂuid), capturing the
essence of the venous compliance of the body. The ﬂuid
then reenters the ventricular chamber where it is recharged
by incoming pressure from the linear actuator on the buffer
chamber. Fig 2 shows a schematic of the Hemodynamic
Simulator. The arm vasculature was placed between the
aortic and venous compliance chambers.
Test conﬁgurations. To analyze the hemodynamics of
the arm vasculature, four primary test conﬁgurations were
established: native circulation (NC), with an AVF, and
with a DRIL and AVF with and without IL. In the NC,
the ﬂuid traveled from the aorta to the subclavian and axil-
lary arteries, to the brachial artery, then to the radial and
ulnar bifurcation to converge in the capillary bed compli-
ance chamber. Fluid then returned from the capillary bed
via the distal arm vein and the axillary and subclavian
venous tubing, which contained a one-way check valve,
and ﬁnally through the vena cava. In all of the conﬁgura-
tions, a collateral circulation mimicking the profunda bra-
chii existed from the proximal brachial to the radial artery.
In the AVF conﬁguration, a brachiocephalic AVF was
added to the NC conﬁguration between the midpoint of
the brachial artery to the cephalic vein/axillary vein
conﬂuence just proximal of the venous check valve. The
AVF was 19 cm long and 6 mm in diameter for the
nominal case. In the DRIL, the DR bypass was added
equidistant (5 cm) proximally and distally from the AVF
anastomosis (Fig 3). When DRIL was performed with
interval ligation, the arterial portion distal to the AVF
anastomosis and proximal to the distal DR bypass anasto-
mosis was clamped using an external screw clamp. The DR
bypass was 20 cm long and 6 mm in diameter. Each test
conﬁguration was tested under normotensive pressure
conditions.
RESULTS
The pressure and ﬂow results are presented pictorially
for each test conﬁguration, NC, AVF, DR no IL, and
DRIL (Fig 4). These measurements were taken at four
locations: (1) pressure and ﬂow proximal to the capillary
bed representing pressure and ﬂow to the hand; (2) ﬂow
in the brachial artery distal to the AVF anastomosis; (3)ﬂow in the AVF itself; and (4) ﬂow in the DR bypass.
The baseline arterial and venous pressures and waveforms
were physiologic (Fig 5). Furthermore, the relationship
between dP (change in distal pressure from the distal arte-
rial to distal venous side) and the distal ﬂow as well as
a summary is listed in the Table.
Native circulation. In the native circulation, the ﬂow
in the brachial artery was 133 mL/min (antegrade). This
resulted in a mean distal arterial pressure of 76 mm Hg,
a distal venous pressure of 31 mm Hg, and a mean blood
ﬂow rate of 152 mL/min. The pulse pressure for this
conﬁguration was 65 mm Hg at the subclavian/aorta
bifurcation. There were no AVF or DR bypass ﬂows to
study in this conﬁguration.
AVF. When a 6-mm brachiocephalic AVF was placed
in the normal circulation under normotensive conditions,
a 15% decrease in distal arterial pressure and a 65% decrease
in distal ﬂow are seen. Distal arterial pressure dropped from
76 mm Hg to 64 mm Hg in the NC to the AVF, respect-
fully. The distal venous pressure was 49 mm Hg. Distal
ﬂow dropped from 151 mL/min to 54 mL/min from
the NC to the AVF. Flow through the distal brachial artery
was 13 mL/min (antegrade), and ﬂow through the AVF
was 936 mL/min. The arterial pulse pressure in the AVF
conﬁguration was 61 mm Hg.
DR no IL. When the 6-mm DR bypass was placed
with no interval ligation, no change in distal pressure and
a 27% increase in distal ﬂow was seen as compared with
the AVF. Distal arterial pressure remained constant at 64
mm Hg, and distal ﬂow increased from 54 to 68 mL/
min from the AVF to DR no IL. Distal venous pressure
was 50 mm Hg. Flow through the distal brachial artery
was 304 mL/min (retrograde). Flow through the AVF
was 973 mL/min. Flow through the DR bypass was 329
mL/min. Arterial pulse pressure in this conﬁguration was
62 mm Hg.
DRIL. When the 6-mm DR bypass was placed with
IL, a 3% increase in distal pressure and a 15% increase in
distal ﬂow was seen as compared with DR no IL and
a 3% increase in distal pressure and 46% increase in distal
ﬂow as compared with AVF. Distal arterial pressure
increased from 64 to 66 mm Hg, and distal ﬂow increased
from 68 to 79 mL/min from DR no IL to DRIL. Distal
venous pressure was 48 mm Hg. Flow through the distal
brachial artery was 0 mL/min due to the ligation. Flow
through the AVF was 923 mL/min. Flow through the
DR bypass was 55 mL/min with IL, decreased from 329
mL/min without IL. Pulse pressure was found to be 61
mm Hg on the proximal arterial side at the same location
noted above.
DISCUSSION
The hemodynamic analysis of AVF and related
ischemic steal has been the subject of many in vivo and
in vitro studies. For many of these models, certain assump-
tions or experimental conditions have limited the accuracy
and clinical application of the results. Through the creation
of a novel, in vitro, pulsatile model, the hemodynamics of a
Fig 3. Conﬁguration of the ﬁnal experimental setup. The distal revascularization and interval ligation (DRIL) bypass
and IL (dashed line) are shown with the black arrows indicating the direction of ﬂow. The elimination of the DRIL
bypass and the IL would result in the arteriovenous ﬁstula (AVF) conﬁguration. The AVF is a bridge between the
arterial and venous circulation. The native circulation would result in the elimination of the DRIL and AVF from the
picture shown.
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with and without IL, were studied. The DR bypass
augmented distal blood ﬂow with IL, showing improve-
ment in distal ﬂow at the sacriﬁce of decrease in ﬂow
through the DR bypass. The addition of the DRIL conﬁg-
uration maintained AVF ﬂow rates. The speciﬁcs of these
ﬁndings are discussed in conjunction with the limitationsof this model and its potential applications for both testing
and training.
This model, derived from several models, such as early
electrical models created by Windkessel14 and Wixon,15
and physical models such as that created by Zanow,16 coa-
lesces important physical considerations. Speciﬁcally, in this
model, a consideration for vessel compliance, a fully
Fig 5. Physiologic pressure waveforms from in vitro arterial and
venous circulation. The top line represents the arterial pressure
(pulse pressure of 65 mm Hg) at the subclavian-aorta bifurcation.
The dashed line represents the distal venous pressure. The wave-
forms were generated by the hemodynamic simulator.
Fig 4. Comparison of the changing hemodynamics under the test conﬁgurations of the native circulation (NC),
arteriovenous ﬁstula (AVF), distal revascularization without interval ligation (DR no IL), and full distal revascularization
and interval ligation (DRIL) procedure. dP represents the change in distal pressure between the arterial and venous sides.
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venous circulation allow this in vitro model to incorporate
necessary attributes of the in vivo system. This has resulted
in measurements that can be translated to actual clinical
situations.Above, it is shown that with the creation of an AVF,
large sacriﬁces of pressure and ﬂow to the hand are made
in order to sustain hemodynamic access. Fluid ﬂows from
points of high to low pressure, and the ﬂow rate is a func-
tion of this pressure gradient, dP. It became apparent that
the venous side of the AVF acts as a point of low pressure,
while the most proximal artery acts as a point of high pres-
sure. The AVF acts as a low resistance shunt between the
artery and vein, drastically decreasing (from 44 mm Hg
in NC case to 15 in AVF) the dP between them by both
decreasing the arterial pressure and increasing the venous
pressure. Because this is the same dP that drives ﬂow
through the hand, the distal ﬂow decreased by a similar
ratio (151 to 54).
The pressure source propels ﬂuid, and inversely, a pres-
sure sink draws ﬂuid in. Functioning as a route around this
pressure sink, a DR bypass augments blood ﬂow to the
hand. Furthermore, when IL was not performed in
conjunction with the DR bypass, blood ﬂow was found
to aggressively retreat retrograde from the DR bypass anas-
tomosis into the AVF. It is therefore proposed that, in
Table. Pressures and ﬂows presented for each test
conﬁguration
NC AVF DR no IL DRIL
Distal brachial artery ﬂow,
mL/min
133 13 304 0
Distal ﬂow, mL/min 151 54 68 79
AVF, mL/min – – 973 923
DRIL, mL/min – – 329 55
Distal arterial pressure, mm Hg 76 64 64 66
Distal venous pressure, mm Hg 31 49 50 48
dP to hand, mm Hg 44 15 14 18
Pulse pressure, mm Hg 65 61 62 61
AVF, Arteriovenous ﬁstula, DRIL, distal revascularization with interval
ligation; DR no IL, distal revascularization without interval ligation; NC,
native circulation.
dP represents the change in pressure from the distal arterial pressure to the
distal venous pressure.
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brachial artery and into the AVF from the DR bypass, IL
must be performed. Additionally, IL resulted in augmenta-
tion of blood ﬂow and pressure to the distal hand above
that seen with DR no IL. The ﬁnding that IL resulted in
a decrease in ﬂow through the DR bypass itself suggests
implications for DRIL procedures based on conduit avail-
ability. More speciﬁcally, when prosthetic or disadvantaged
conduits must be used, not performing the IL may allow
for higher ﬂow rates through the bypass at a sacriﬁce for
additional increases in distal ﬂow rates.
The DR with or without IL maintained AVF ﬂow rates
while concurrently improving distal blood ﬂow. This
provides hemodynamic evidence and support to the clinical
data that AVF patency is higher with DRIL procedures
than with restrictive procedures aimed at decreasing the
diameter of the AVF distal to the anastomosis. These
restrictive procedures augment distal ﬂow through
increases in AVF resistance, which results in decreases in
AVF ﬂow. This decrease in ﬂow is the contributing factor
to the higher associated AVF thrombosis and failure. The
maintained AVF ﬂow with DRIL suggests that this recon-
struction for ischemic steal may be advantageous.
Some of the apparent advantages of an in vitro system
are the ability to create repeatable, reliable results without
the use of animals. This model can be easily modiﬁed to
hemodynamically characterize revision using distal inﬂow
or proximalization of arterial inﬂow conﬁgurations or can
be adjusted for patient-speciﬁc situations. Although in
this study only normotensive conditions were tested, due
to the versatility of the heart simulator pump, along with
various ﬁstula conﬁgurations, hypertensive conditions can
be simulated by increasing peripheral resistance. This also
provides the opportunity to create personalized AVF
conﬁgurations based on patients’ anatomy and hemody-
namics. The intention of this personalization would be to
decrease access-related ischemia and increase AVF matura-
tion and functionality.
A discrepancy between the distal ﬂow and distal pres-
sure changes can be seen. We observe a more dramaticincrease in distal ﬂow as compared with distal pressure
when moving from the AVF to DR no IL and to DRIL
conformations. This can be explained from the equation
DP ¼ R  Q, where P is pressure, R is resistance, and Q
is ﬂow rate. Considering the control volume of the arm
circulation, with the addition of the AVF, the effective total
resistance that the ﬂow experiences decreases due to the
fact that the ﬂow can now bypass the higher resistance
network of the hand through the AVF. Thus, the
increasing distal ﬂow and the counteracting decreasing
network resistance yields a resultant DP that changes only
minimally.
One of the limitations of this model is that the in vitro
system is neither a changing nor adapting environment like
the true in vivo system by which it is modeled. In vivo, one
would expect the AVF to progressively dilate once exposed
to the high-ﬂow environment. This compensatory mecha-
nism, however, is not modeled accurately using this
in vitro model. Additionally, with AVF maturation comes
the creation of a low pressure point to which ﬂow is drawn.
This in turn, promotes changes in the patient’s cardiac
output, collateral artery formation, and increased proximal
brachial artery diameter. This adapting environment is difﬁ-
cult to simulate. Finally, this model reﬂects hemodynamic
rather than clinical representations of distal ischemia. Steal
is more commonly diagnosed based on hand pain, pallor,
and lack of motor function and not on hemodynamic
end points of distal ﬂows and pressure. Future development
of this research includes the correlation of distal hand pres-
sure and ﬂow parameters before and after an AVF or DRIL
procedure to clinical symptomatology.
This model also provides the basis of an educational
simulator. Clinical trainees can observe instantaneous
changes in the ﬂows and pressures of the system after the
creation of an AVF, verify the beneﬁts and caveats of the
DRIL procedure, as well as alter conﬁgurations of both
procedures to observe the hemodynamic outcomes. The
pulsatile system also has the ability to simulate open
vascular surgery for other anatomic locations. This includes
studying varying anastomotic conﬁgurations, learning the
hemodynamics after vascular clamp placement and arterio-
tomy, and assessing the effectiveness and hemostasis of
vascular suturing.
CONCLUSIONS
Through the construction and validation of an in vitro,
pulsatile arteriovenous model, the intricate hemodynamics
of AVF and treatments for ischemic steal can be studied.
The ﬁndings of the AVF as a pressure sink and the relative
role of IL with DR bypass has allowed this model to
provide hemodynamic insight difﬁcult or impossible to
obtain in animal or human models. We observed: (1) the
DR with or without IL maintains AVF ﬂow rates
unchanged from the native state; and (2) the DR bypass
can be performed without IL to promote a higher ﬂow
rate through the bypass at a smaller sacriﬁce to distal ﬂow
and pressure. Further study of these phenomena with this
model should allow for more effective AVF placement
JOURNAL OF VASCULAR SURGERY
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ated ischemic steal.
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your modeling the vasoreactivity changes? One of the problems we
have is that arteries aren’t always nice soft vessels. Do your models,
either the plastic model or the computerized model, take into
account calciﬁcation and loss of vasoreactivity?
Dr Ankur Chandra. Actually, what we’re working on now
is currently a method of being able to use angiographic method
to determine downstream vascular resistance and then incorpo-
rating that vascular resistance, such as calciﬁcations, into the
program, which will allow a modiﬁcation of that patient-speciﬁc
diagram.
Dr April Boyd (Winnipeg, Manitoba, Canada). Have you
done any particle velocimetry to look at the actual ﬂow dynamics
in the model to see how closely you’re predicting ﬂow?
Dr Chandra. That’s a terriﬁc idea. And in fact, that’s one of
our next set of experiments is both validating the computationalﬂuid dynamic model with the in vitro model. And the beneﬁt of
the in vitro modeling is that we could very easily input particles
or dye or other characteristics, image them, and do exactly that.
So that’s what we do plan to do in the future.
Dr Peter Lawrence (Los Angeles, Calif). Please comment
about the role of imaging, and particularly MRA, in your model.
A lot of what you showed us could be imaged with MRA,
including not only larger vessel diameter and anatomy, but also
ﬂow, not only through the vessels but also the tissues.
Dr Chandra. I think that’s actually exactly right. In fact, the
next stage that we’re going to expand into is obviously gathering
clinical data from clinical imaging, so either angiographic imaging
at the time of a ﬁstulogram or MRI imaging. Because obviously we
have already correlated this with preliminary clinical data, but
correlating it over a larger scale will require both either MRI
and/or angiographies.
